MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress

Biochemical and Biophysical Research Communications

Volumn 440, Issue 1, 2013, Pages 179-183

  Chen, Qiongqiong ^a   Li, Decai ^a   Ren, Jian ^a   Li, Chenghua ^a   Xiao, Zhi Xiong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; DNA damage; JNK; MUC1

Indexed keywords

CISPLATIN; MUCIN 1; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CELL STRAIN HCT116; CELL STRESS; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING;

APOPTOSIS; DNA DAMAGE; JNK; MUC1;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COLON; COLONIC NEOPLASMS; DNA DAMAGE; ENZYME ACTIVATION; HCT116 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MUCIN-1; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84885373701     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.055     Document Type: Article

References (39)

1. Perey L., Hayes D.F., Maimonis P., Abe M., O'Hara C., Kufe D.W. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res. 1992, 52:2563-2568.
2. Macao B., Johansson D.G., Hansson G.C., Hard T. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol. 2006, 13:71-76.
3. Kufe D.W. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2013, 32:1073-1081.
4. Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 1988, 263:12820-12823.
5. Kufe D.W. Functional targeting of the MUC1 oncogene in human cancers. Cancer Biol. Ther. 2009, 8:1197-1203.
6. Singh R., Bandyopadhyay D. MUC1: a target molecule for cancer therapy. Cancer Biol. Ther. 2007, 6:481-486.
7. Raina D., Kharbanda S., Kufe D. The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J. Biol. Chem. 2004, 279:20607-20612.
8. Ren J., Agata N., Chen D., Li Y., Yu W.H., Huang L., Raina D., Chen W., Kharbanda S., Kufe D. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004, 5:163-175.
9. Raina D., Ahmad R., Kumar S., Ren J., Yoshida K., Kharbanda S., Kufe D. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J. 2006, 25:3774-3783.
10. Li Y., Liu D., Chen D., Kharbanda S., Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003, 22:6107-6110.
11. Dunn C., Wiltshire C., MacLaren A., Gillespie D.A. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal. 2002, 14:585-593.
12. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
13. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996, 15:2760-2770.
14. Ho C.Y., Li H.Y. DNA damage during mitosis invokes a JNK-mediated stress response that leads to cell death. J. Cell. Biochem. 2010, 110:725-731.
15. Martinovic V., Grigorov I., Bogojevic D., Petrovic A., Jovanovic S., Ilic M., Ivanovic Matic S. Activation level of JNK and Akt/ERK signaling pathways determinates extent of DNA damage in the liver of diabetic rats. Cell. Physiol. Biochem. 2012, 30:723-734.
16. Murai H., Hiragami F., Kawamura K., Motoda H., Koike Y., Inoue S., Kumagishi K., Ohtsuka A., Kano Y. Differential response of heat-shock-induced p38 MAPK and JNK activity in PC12 mutant and PC12 parental cells for differentiation and apoptosis. Acta Med. Okayama 2010, 64:55-62.
17. Scudiero I., Zotti T., Ferravante A., Vessichelli M., Reale C., Masone M.C., Leonardi A., Vito P., Stilo R. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFalpha-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J. Biol. Chem. 2012, 287:6053-6061.
18. Hoffmann E., Ashouri J., Wolter S., Doerrie A., Dittrich-Breiholz O., Schneider H., Wagner E.F., Troppmair J., Mackman N., Kracht M. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J. Biol. Chem. 2008, 283:12120-12128.
19. Dhanasekaran N., Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene 1998, 17:1447-1455.
20. Sabapathy K., Hochedlinger K., Nam S.Y., Bauer A., Karin M., Wagner E.F. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 2004, 15:713-725.
21. Suzuki H., Matsuoka M. The JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death. Mol. Cell. Biochem. 2013, 372:241-248.
22. Bost F., McKay R., Bost M., Potapova O., Dean N.M., Mercola D. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 1999, 19:1938-1949.
23. Lee Y.J., Shukla S.D. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur. J. Pharmacol. 2005, 508:31-45.
24. Ma J., Zhang L., Han W., Shen T., Ma C., Liu Y., Nie X., Liu M., Ran Y., Zhu D. Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells. J. Lipid Res. 2012, 53:1093-1105.
25. Ren J., Li Y., Kufe D. Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J. Biol. Chem. 2002, 277:17616-17622.
26. Sdek P., Ying H., Zheng H., Margulis A., Tang X., Tian K., Xiao Z.X. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth. J. Biol. Chem. 2004, 279:53317-53322.
27. Li Y., Kuwahara H., Ren J., Wen G., Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 2001, 276:6061-6064.
28. Huang L., Chen D., Liu D., Yin L., Kharbanda S., Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res. 2005, 65:10413-10422.
29. Li Y., Bharti A., Chen D., Gong J., Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol. Cell. Biol. 1998, 18:7216-7224.
30. Yoshida K., Miki Y., Kufe D. Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage. J. Biol. Chem. 2002, 277:48372-48378.
31. Smeal T., Binetruy B., Mercola D.A., Birrer M., Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 1991, 354:494-496.
32. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22:3876-3886.
33. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 1998, 10:205-219.
34. Kuntzen C., Sonuc N., De Toni E.N., Opelz C., Mucha S.R., Gerbes A.L., Eichhorst S.T. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res. 2005, 65:6780-6788.
35. Herr I., Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 2001, 98:2603-2614.
36. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat Med. 2000, 6:513-519.
37. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003, 25:17-24.
38. Liu J., Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 2005, 15:36-42.
39. Ahmad R., Alam M., Rajabi H., Kufe D. The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function. J. Biol. Chem. 2012, 287:20866-20875.